Trillium Therapeutics to Present Clinical Data at the 62nd American Society of Hematology Annual Meeting Biotech Investing
AbbVie to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference Biotech Investing
MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines Psychedelics Investing
Bausch Health Initiates Second Phase 3 Study For NOV03 Investigational Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunction Medical Device Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
